Next Article in Journal
Percutaneous Coronary Intervention Is Not Superior to Optimal Medical Therapy in Chronic Coronary Syndrome: A Meta-Analysis
Next Article in Special Issue
Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients
Previous Article in Journal
The PD-L1 Expression and Tumor-Infiltrating Immune Cells Predict an Unfavorable Prognosis in Pancreatic Ductal Adenocarcinoma and Adenosquamous Carcinoma
Previous Article in Special Issue
Comparative Effectiveness of Apixaban and Rivaroxaban Lead-in Dosing in VTE Treatment: Observational Multicenter Real-World Study
 
 
Perspective

Article Versions Notes

J. Clin. Med. 2023, 12(4), 1399; https://doi.org/10.3390/jcm12041399
Action Date Notes Link
article pdf uploaded. 9 February 2023 17:04 CET Version of Record https://www.mdpi.com/2077-0383/12/4/1399/pdf-vor
article xml file uploaded 21 February 2023 10:28 CET Original file -
article xml uploaded. 21 February 2023 10:28 CET Update https://www.mdpi.com/2077-0383/12/4/1399/xml
article pdf uploaded. 21 February 2023 10:28 CET Updated version of record https://www.mdpi.com/2077-0383/12/4/1399/pdf
article html file updated 21 February 2023 10:29 CET Original file https://www.mdpi.com/2077-0383/12/4/1399/html
Back to TopTop